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ABSTRACT
Introduction: The UK government recommends that
at least 75% of people aged under 64 with certain
conditions receive an annual influenza vaccination.
Primary care practices often fall short of this target and
strategies to increase vaccine uptake are required. Text
messaging reminders are already used in 30% of
practices to remind patients about vaccination, but
there has been no trial addressing their effectiveness in
increasing influenza vaccine uptake in the UK.
The aims of the study are (1) to develop the
methodology for conducting cluster randomised trials
of text messaging interventions utilising routine
electronic health records and (2) to assess the
effectiveness of using a text messaging influenza
vaccine reminder in achieving an increase in influenza
vaccine uptake in patients aged 18–64 with chronic
conditions, compared with standard care.
Methods and analysis: This cluster randomised trial
will recruit general practices across three settings in
English primary care (Clinical Practice Research
Datalink, ResearchOne and London iPLATO text
messaging software users) and randomise them to
either standard care or a text messaging campaign to
eligible patients. Flu vaccine uptake will be ascertained
using routinely collected, anonymised electronic patient
records. This protocol outlines the proposed study
design and analysis methods.
Ethics and dissemination: This study will determine
the effectiveness of text messaging vaccine reminders in
primary care in increasing influenza vaccine uptake, and
will strengthen the methodology for using electronic health
records in cluster randomised trials of text messaging
interventions. This trial was approved by the Surrey
Borders Ethics Committee (13/LO/0872). The trial results
will be disseminated at national conferences and published
in a peer-reviewed medical journal. The results will also be
distributed to the Primary Care Research Network and to all
participating general practices.
Trial registration number: This study is registered at
controlled-trials.com ISRCTN48840025, July 2013.
INTRODUCTION
Inﬂuenza morbidity and mortality causes a
substantial ﬁnancial burden to the National
Health Service and to the UK as a whole.
Inﬂuenza vaccine is safe and effective but is
required annually because the circulating
strain of the virus changes each year. In the
UK in 2012, the Chief Medical Ofﬁcer
recommended that at least 75% of elderly
people (aged 65+) and 75% people under
65 with certain chronic conditions (eg,
chronic heart disease, diabetes, asthma, etc)
should be vaccinated.1
While many primary care practices are
achieving these targets for elderly patients
(74% vaccinated in 2011/2012), those set for
patients with chronic conditions are not
being met and have shown no substantial
increases in the past decade2; vaccine uptake
in 2011/2012 was 51.6% across the risk
groups (see online supplementary table S1).
Barriers to inﬂuenza vaccination in the UK
include the lack of recommendation for vac-
cination by a healthcare worker,3 lack of
awareness of eligibility for vaccination,4 low
perceived susceptibility to and severity of
inﬂuenza,3–5 beliefs that the effectiveness of
the vaccine is low, and beliefs about its side
effects, safety and pain.3 5 Strategies to
increase ﬂu vaccine uptake are required.
Several randomised trials have demon-
strated the effectiveness of ﬂu vaccine remin-
ders delivered to patients by letter, postcard
Strengths and limitations of this study
▪ This trial is the first to evaluate the effectiveness
of text messaging for influenza vaccine remin-
ders in English primary care.
▪ Text messaging is cheap, quick and has shown
to be effective for appointment reminders.
▪ The study requires minimal input from practices
as it uses routinely collected electronic health
records to gather vaccine uptake data.
▪ There may be some contamination if general
practices in the standard care arm choose to
send a text message.
Herrett E, van Staa T, Free C, et al. BMJ Open 2014;4:e004633. doi:10.1136/bmjopen-2013-004633 1
Open Access Protocol
 group.bmj.com on July 17, 2014 - Published by bmjopen.bmj.comDownloaded from 
or telephone.6 7 However, the use of text messaging in
the NHS for appointment reminders is increasing as it is
cheap, quick and effective. Text messaging is already
used in roughly 30% of practices to remind patients
about their ﬂu vaccine,8 but there has been no trial
addressing its effectiveness in this context. Trials of text
messaging in the USA have shown some success as
vaccine reminders,9 but whether there is an effect in UK
primary care is unknown.
Therefore, we are performing a randomised trial of a
text messaging ﬂu vaccine reminder in patients aged
under 65 who have a chronic condition (as described in
online supplementary table S1). We will randomise
whole primary care practices to either a text messaging
campaign to eligible patients or to standard care
(chosen as the comparator group because practices cur-
rently employ a variety of methods to encourage at-risk
patients for inﬂuenza vaccine).8
AIMS AND OBJECTIVES
The aims of the study are (1) to develop the method-
ology for conducting cluster randomised trials of text
messaging interventions using routine electronic health
records and (2) to implement a cluster randomised trial
to test the effectiveness of using a text messaging inﬂu-
enza vaccine reminder in achieving an increase in inﬂu-
enza vaccine uptake in patients aged 18–64 with chronic
conditions compared with standard care.
Speciﬁc objectives are: (1) to evaluate the effect of
text messaging inﬂuenza vaccination reminders in
patients under 65 with chronic conditions; (2) to evalu-
ate the feasibility of recruiting and randomising prac-
tices to a text messaging intervention; (3) to evaluate
the feasibility of practice delivery of a text message inter-
vention to eligible patients within a primary care setting
and (4) to evaluate the feasibility of ascertaining practice
data regarding text message delivery and ﬂu vaccine
uptake.
METHODS
Study design
A cluster randomised trial10 11 of a text messaging inﬂu-
enza vaccination reminder in primary care.
Study population
This study is taking place in English primary care, with
general practices recruited from three settings: (1) the
Clinical Practice Research Datalink (CPRD),12 a primary
care database based on Vision software and covering 8%
of the UK population; (2) ResearchOne, a primary care
database based on TPP SystmOne software13 and cover-
ing 7.6% of the UK population and (3) iPLATO text
messaging software users in London.14
Inclusion criteria
Eligible practices must currently use a text messaging
system to communicate with patients about issues other
than inﬂuenza vaccination (CPRD and London practices
must use iPLATO,14 ResearchOne practices must use TPP
SystmOne text messaging software. Practices using other
text messaging software will be excluded). Practices that
used text messages for inﬂuenza vaccination reminders in
the 2012/2013 inﬂuenza season will be excluded.
Recruitment
Eligible practices in the CPRD (n=40) will be identiﬁed
using the electronic health record and invited to the
trial. All TPP SystmOne practices (n=2073) and
London-based iPLATO practices (n=460) will be invited
to the trial by the Primary Care Research Network.
London iPLATO practices will also be contacted by
iPLATO and TPP SystmOne practices will be targeted
through SystmOne communications. The Primary Care
Research Network15 will be involved in practice recruit-
ment to ensure that the target sample size is reached.
Sample size calculation
The sample size calculation is based on a comparison
between inﬂuenza vaccine uptake in the intervention
group, in which a text message inﬂuenza vaccination
reminder will be sent to eligible patients, and inﬂuenza
vaccine uptake in the standard care group. A cluster-
level analysis of the practice-speciﬁc proportions will be
undertaken and the sample size calculation estimates
the number of practices required for the study. A system-
atic review of reminders for inﬂuenza vaccination
reported that reminders (of any type) for inﬂuenza
vaccine among adults increased the uptake, with an OR
of 1.66, 95% CI 1.31 to 2.09).16 However, a text messa-
ging vaccine reminder trial among children in the USA
found only a 9% increase (RR=1.09, 95% CI 1.04 to
1.15).9 Therefore, we have chosen to power our study
for a risk ratio of 1.075, representing an increase from
54% (uptake in the CPRD 2012/2013) to 58%.
At 90% power and 5% signiﬁcance, with an ICC by
general practice of 0.024 and an average of 750 eligible
patients per practice, we will require 100 practices (50
per arm) to identify a 7.5% increase in vaccine uptake
from 54% to 58%. To account for differences in the
number of eligible patients per practice and the propor-
tion with mobile phone numbers recorded, we have
chosen to recruit and randomise 150 practices to the
study.
Assignment of interventions
Practices will be randomised on a 1:1 basis to the inter-
vention and standard care groups. We will use block ran-
domisation within each setting. In the CPRD and
ResearchOne, we will stratify by region. The allocation
sequence will be generated by an independent statisti-
cian who will be blinded to practice name and the allo-
cation sequence will be concealed from the study team.
Once practices have been allocated, the trial coordinator
will inform practices about their allocation and distrib-
ute study materials.
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Blinding
Practices in this study will be randomised to intervention
or standard care groups, but general practice staff will
not be blinded. However, academic investigators and
trial statisticians will manage and review data without
knowledge of the allocation.
Interventions
Practices will be allocated to an intervention or standard
care arm. Those in the intervention arm will be asked to
send an inﬂuenza vaccination text message reminder to
their under 65 at-risk patients. This includes patients
who are under 65 with chronic heart disease, chronic
neurological disease, diabetes, chronic kidney disease,
chronic liver disease, chronic respiratory disease and
immunosuppression, as set out by the Chief Medical
Ofﬁcer.17 Most practices will identify eligible patients
based on their electronic medical records using their
established systems. Practices use a standard set of Read
codes (available from Primis18) to determine patient eli-
gibility for inﬂuenza vaccination.
The message content that practices will be asked to
send is shown in box 1. This single text message was
designed to be a pragmatic, uncomplicated intervention
that would not discourage practices from participating,
but that aims to address some of the key barriers to vac-
cination.3 It was speciﬁcally designed to target more
than one factor inﬂuencing behaviour: ﬁrst, the text
message represents a recommendation from the general
practitioner (GP); second, it indicates the severity of ﬂu
and that the patient is susceptible to ﬂu; third, it acts as
a prompt to patients who might have simply forgotten to
make an appointment.
Practices in the intervention group will receive guid-
ance notes regarding delivery of the message (content,
timing, eligible patients) and an incentive payment of
£200. Practices will be instructed to continue with any
other aspect of their seasonal ﬂu campaign as planned,
in addition to the text message. An online questionnaire
will be sent to practices in the intervention arm to ascer-
tain feedback from practice staff about delivery of the
intervention.
Practices allocated to the standard care group will be
asked to continue with their seasonal ﬂu campaign as
planned.
Substudy for patient feedback
A substudy will be conducted in two participating inter-
vention practices. Each practice will send an anonymous
questionnaire to patients who were targeted with the
text message reminder. This questionnaire will address
patient acceptability of the text message.
Outcomes
The aims of the study are (1) to develop the method-
ology for conducting cluster randomised trials of text
messaging interventions using routine electronic health
records and (2) to implement a cluster randomised trial
to test the effectiveness of using a text messaging inﬂu-
enza vaccine reminder in achieving an increase in inﬂu-
enza vaccine uptake in patients aged 18–64 with chronic
conditions compared with standard care.
To address aim 2, we will examine the proportion of
eligible patients who received the inﬂuenza vaccination
by 31 December 2013 (primary outcome). This will be
stratiﬁed by risk group, age and sex. A secondary
outcome will be the proportion of eligible patients who
were sent a text message to remind them about ﬂu
vaccine.
To address aim 1, we will measure the following as sec-
ondary outcomes:
▸ Practice recruitment rate (based on the number of
practices invited across three trial settings, and the
number recruited);
▸ The proportion of intervention practices and stand-
ard care practices that sent a text message to eligible
patients;
▸ The proportion of practices reporting any problems
with delivering the message;
▸ The availability of data to examine text message
receipt and vaccine uptake in each risk group;
▸ The time and cost required to gather data.
In the patient substudy, we will also examine the
acceptability of text messaging to patients, by measuring
the proportion of patients who reported problems with
the text message.
DATA COLLECTION METHODS
All patient-level outcomes will be evaluated through ana-
lysis of routinely collected data. In practices that contrib-
ute data to the CPRD or ResearchOne, relevant data will
be extracted from the database using speciﬁed Read
codes. Within London practices using iPLATO software,
data will be extracted by the clinical software supplier of
the practice or the practices themselves.
We will extract data on age, sex, clinical risk group
(based on historical data from the medical record and
prescription data), vaccination reminder type (text,
letter, phone call, face to face), vaccination uptake,
death, transfer out of practice, ﬂu and ﬂu-like illness,
and hospital admissions. Uptake and patient outcomes
will be analysed from 1 September to 31 December
2013. All of these data items are routinely collected by
general practices and stored in their electronic health
record, and follow-up for practices will be complete
using this method. Time and cost of data collection
using these methods will be estimated. All data will be
Box 1 Recommended text message content in the trial
intervention arm.
Hello PATIENT NAME, to reduce your risk of serious health pro-
blems from flu, we recommend vaccination. Call PRACTICE
PHONE NUMBER to book. PRACTICE NAME.
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stripped of personal identiﬁers before being supplied to
the study team, and will be stored securely as deﬁned in
the protocol.
We will record the number of practices approached,
recruited and analysed. An online questionnaire,
emailed to each practice in the intervention group, will
ascertain practice acceptability of the intervention. The
postal questionnaire to patients in the substudy will esti-
mate patient acceptability.
STATISTICAL METHODS
A cluster-level analysis will be performed using practice-
speciﬁc proportions as observations. We will compare
vaccine uptake in the intervention and standard care
groups using a t test, with the size of clusters taken into
account. A series of descriptive statistics will describe the
methodological outcomes.
Sensitivity and subgroup analyses
Our primary analysis will be an intention to treat ana-
lysis. However, to account for any contamination
between the standard care and intervention arms, we
will carry out a per-protocol analysis.
Where available, we will also measure the difference in
vaccine uptake, comparing practices that used the exact
wording of the message in the study protocol with prac-
tices that used an alternative message. We hypothesise
that practices using our message (based on behavioural
theory) will have a higher uptake than an alternative
designed by the practice. As this will be a non-
randomised comparison, we will adjust for confounders.
Finally, we will compare the effectiveness of the text
message based on the time of day that it was sent to
patients. We hypothesise that messages sent in the late
afternoon will have more effect than those sent at
earlier times of the day, when patients may not have the
time to respond.
Hawthorne effect
The study design allows an evaluation of the generalis-
ability of the study population; practices that take part in
the study can be compared with other practices outside
of the trial that contribute data to ResearchOne and
CPRD. We will test whether participation in the trial
changes the behaviour of practices in their use of text
messaging (Hawthorne effect).
This study will provide evidence regarding the effect-
iveness of text messaging reminders for inﬂuenza
vaccine in patients under 65 with chronic conditions.
The methodology here will be applied to future cluster
randomised trials of text messaging interventions within
electronic heath records.
ETHICS AND DISSEMINATION
Ethical issues
Approvals
The study protocol (V.2.7, 11/02/2014) has received a
favourable opinion from the National Research Ethics
Service Committee—Surrey Borders (REC number
13/LO/0872) and has also received assurance from par-
ticipating Primary Care Trusts/Clinical Commissioning
Groups. All minor and major amendments to the proto-
col will be approved by the REC, and participating
general practices will be notiﬁed of any protocol amend-
ments relevant to them.
Informed consent
This is a cluster trial and informed consent will be
obtained by the trial coordinator from GPs, who will act
as the guardian of the cluster. A signed and dated
informed consent form is required for participation in
the trial. The risks and beneﬁts of participation will be
explained and GPs are free to decline to participate in
the trial. Individual consent will not be sought. This is
justiﬁed because participating practices already use text
messaging to communicate with patients, although not
systematically for inﬂuenza. Patients within these prac-
tices will have the opportunity to opt out of receiving
messages if they do not wish to be contacted in this way.
Patient confidentiality
All patient-level data accessed in this study will be
stripped of personal identiﬁers.
Access to data
The data will be accessed only by authorised persons
from the London School of Hygiene and Tropical
Medicine and research governance authorities to ensure
that the study is being carried out to acceptable stan-
dards. All will have a duty of conﬁdentiality and no data
will be disclosed outside the research site. All patient-
level and practice-level information will be conﬁdential.
Burden and risk to practices
Text messaging is widely used in everyday primary care
and the only substantive change from non-study is the
random allocation of a deﬁned text message regarding
inﬂuenza vaccine rather than the practice’s own seasonal
ﬂu campaign. Patients can opt out of receiving text mes-
sages from their practices, and as part of this study, we
will monitor patient and practice complaints regarding
the text message. Patients registered at practices in the
intervention arm will receive one text message regarding
their ﬂu vaccine to minimise irritation to patients.
Participating practices must spend time identifying eli-
gible patients and sending a text message. We are redu-
cing this burden by (1) asking practices to use
established procedures and software to identify eligible
patients for vaccination. This is a task that they would
perform annually in non-study conditions; (2), we are
including only practices that are familiar with the text
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messaging software, which minimises time spent in famil-
iarisation with the software and sending messages; (3)
additional support is available to any practice through a
guidance document and/or dedicated support helpline
and (4) we are providing an incentive payment (£200)
to practices in the intervention group to encourage
participation.
Practices may experience increased demand for inﬂu-
enza vaccination appointments or run out of vaccine
supplies sooner than expected. The increase in uptake
is unlikely to be large and will help the practice to
achieve their Quality and Outcomes Framework target
for vaccination, for which they receive payment.
Benefits for practices
Practices in the intervention arm will receive a £200
incentive to participate. If the text message is effective,
then increased uptake will result in additional incentive
payment to GPs by the government and will help them
reach their Quality and Outcomes Framework targets.
The results of this trial will allow practices to make an
informed decision about spending of their budget on
the seasonal inﬂuenza campaign.
Dissemination plans
The results of this trial will be published according to
the guidelines of the CONSORT statement. The results
will be published in a peer reviewed medical journal
and presented at national conferences. The results will
also be distributed to the Primary Care Research
Network and to all participating general practices.
Authorship for all publications will be based on the cri-
teria deﬁned by the International Committee of Medical
Journal Editors.19
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